Merck loses ‘bellwether’ Fosamax case

Jury hands out $285,000 verdict against osteoporosis drug By Eric Palmer You win some and you lose some and this time, Merck ($MRK) lost to the tune of $285,000 when a jury said it ...

HeartMate sales propel Thoratec’s Q4 revenue jump

By Damian Garde Thanks to a 15.5% leap in sales for its signature devices, Thoratec ($THOR) posted a 17% revenue jump in the fourth quarter, and the devicemaker expects to keep cashing ...

Zoll gains Japan’s sign-off for intravascular temperature management device

By Mark Hollmer Zoll Medical won a coveted regulatory approval in Japan for its intravascular temperature management device–the first system of its kind to reach the commercial ...

Glaukos snags $30M venture round for tiny eye stent

By Damian Garde Glaukos, maker of the smallest device ever approved by the FDA, hauled in $30 million in venture funding, headlined by VC giants OrbiMed, InterWest and Facebook ($FB) ...

House Majority Leader Eric Cantor revives device tax repeal push

By Mark Hollmer There’s something to be said for persistence, and opponents of the 2.3% medical device tax certainly have that. Case in point: House Majority Leader Eric Cantor ...

Allergan plans to sell Lap-Band biz by midyear

By Damian Garde Now that it’s done “exploring strategic options,” Allergan ($AGN) is all-in on plans to sell off its obesity-intervention business, expecting to ...

House majority leader Eric Cantor decries the medical device tax

By MassDevice staff  House majority leader Eric Cantor’s (R-Va.) comments on the medical device tax remind that the fight for repeal isn’t over. House majority leader ...

The Cosmetics Wars

By MARK BITTMAN If all goes according to schedule, next month the European Union will become “cruelty-free,” banning without exception the sale of cosmetics ingredients that were ...

Study Looks at Particles Used in Food

By STEPHANIE STROM Nanomaterials, substances broken down by technology into molecule-size particles, are starting to enter the food chain through well-known food products and their ...

European Commission Investigates J&J, Novartis

By Stephanie Sutton. The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules. The EC has issued a Statement of Objections, ...

UPDATE 1-U.S. Senate to mull ban on ‘pay for delay’ pharmaceutical deals

* Branded, generic drug companies expected to oppose bill * Similar measures failed in previous Congress * Supreme Court has agreed to hear ‘pay for delay’ case WASHINGTON, ...

Feeding a Disease With Fake Drugs

By ROGER BATE MORE than eight million people get sick with tuberculosis every year, according to the World Health Organization. In 2011, 1.4 million died from it, making it the world’s ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS